John Chiplin

Endava LLC operates as a global nearshore software development outsourcing company. The firm offers team augmentation solutions to companies of all sizes. It provides solutions for oil and gas software development and digital agencies. The company was founded in 2004 and is headquartered in Bothell, WA.

Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA.

Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper.

TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.

Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA.

Prophecy.io operates as a provider of a SaaS based low code data engineering platform. The company was founded by Raj Bains, Maciej Szpakowski and Vikas Marwaha and is headquartered in Palo Alto, CA.

Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom.

Sienna Cancer Diagnostics Ltd. operates as a medical technology company. It delivers sensitive, novel, robust and test for early detection of cancer, assessment of cancer treatments and assistance in drug development. The company was founded in 2002 and is headquartered in Scoresby, Australia.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

Regeneus Ltd. is regenerative medicine company, which develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Paddington, Australia.

Biotherapy Services Ltd. specializes in wound healing and tissue regeneration using blood-derived products that contain white blood cells and platelets to harness the body's healing properties. The British company is developing the rapid™ biodynamic haematogel wound treatment for complex and slow healing wounds such as diabetic foot ulcers and pressure sores. The treatment is made up of concentrated platelets derived from the patient's own blood, which are activated by autologous thrombin to release healing growth factors, cell signaling molecules, and proteins that work at a cellular level.

Kings Arms Yard VCT Plc a evergreen fund invests in public and private companies located in the UK. The fund targets companies operating in the fields of health technology and services, consumer services and media services. It provides financing for early and later stage transactions. It makes follow on investments.